Frontlight ResearchEarly access
Lung cancer trials in United Kingdom
152 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- Age
- 1 year and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT07440290 - Phase 1/2Taking peopleStudy to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Where
- Glasgow, London, Manchester, Newcastle upon Tyne, Oxford
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT05985655 - Phase 1/2Taking peopleTT-702 in Patients With Advanced Solid Tumours.
- Where
- London, Manchester, Southampton
- Age
- 16 years and over
- People
- 60
- Run by
- Cancer Research UK
See details and how to joinNCT05272709 - Phase 1Taking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Cambridge
- Age
- 18 years and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- London, Sutton
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 2Taking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Leicester, London, Manchester, Newcastle upon Tyne
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - Phase 1Taking peopleClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Where
- Cambridge, Cardiff, Liverpool, London, Newcastle upon Tyne
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- London, Sutton
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Edinburgh, London
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - No phaseNot yet taking people in United KingdomA Pilot Study of the VosCryoTM Breathalyser in Lung Cancer
- Where
- Sheffield
- Age
- 16 years and over
- People
- 24
- Run by
- Sheffield Teaching Hospitals NHS Foundation Trust
See details and how to joinNCT07689968 - No phaseTaking peopleTRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
- Where
- London
- Age
- 18 years and over
- People
- 600
- Run by
- University College, London
See details and how to joinNCT05628376 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Birmingham, London, Sutton
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleClinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
- Where
- London
- Age
- 18 years and over
- People
- 100
- Run by
- Royal Marsden NHS Foundation Trust
See details and how to joinNCT07673861 - Phase 2Taking peopleAutologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Where
- Birmingham, Chelsea, London, Manchester
- Age
- 18 years to 70 years
- People
- 170 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT04614103 · EU 2024-510778-26-00 - No phaseTaking peopleGlasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions - Feasibility Study
- Where
- Glasgow
- Age
- 55 years to 74 years
- People
- 500
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07372508 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Glasgow, Leicester, London, Manchester, Oxford
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 1/2WithdrawnA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Belfast, Cardiff, Glasgow, London, Manchester, Northwood, Preston, Sutton
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - No phaseTaking peopleStrategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department
- Where
- Glasgow
- Age
- 18 years and over
- People
- 17,000
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07391280 - Phase 1/2CompletedA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- London, Manchester, Sutton
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 1/2Taking peopleA Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
- Where
- London, Manchester, Newcastle upon Tyne, Southampton
- Age
- 18 years and over
- People
- 167
- Run by
- Cancer Research UK
See details and how to joinNCT06380816 - No phaseTaking peopleA Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers.
- Where
- Portsmouth
- Age
- 18 years and over
- People
- 140
- Run by
- Portsmouth Hospitals NHS Trust
See details and how to joinNCT07426718 - Phase 2Taking peopleSafety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
- Where
- Cardiff, Leeds, London, Manchester
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06841055 · EU 2024-518279-80-00 - No phaseTaking peopleBronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates - UK
- Where
- London
- Age
- 18 years and over
- People
- 18 worldwide
- Run by
- Creo Medical Limited
See details and how to joinNCT06869122 - Phase 3Active, not recruitingJoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Where
- Middlesbrough
- Age
- 18 years and over
- People
- 272 worldwide
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT02468024 - No phaseTaking peopleClinical Investigation Evaluating the Performance, Safety and Clinical Benefit of the Endowave FlexAblate™ Microwave Ablation System in Patients Undergoing Lung Ablation Procedures.
- Where
- London
- Age
- 18 years and over
- People
- 43 worldwide
- Run by
- Endowave Ltd.
See details and how to joinNCT07291973